US Authorizes Ebola Drug, ZMapp, To Be Sent To Liberia To Treat Infected Doctors

The Liberian government announced Monday that it will get access to ZMapp, the Ebola experimental drug, to treat two local doctors who have contracted the virus in the West African nation. ZMapp, which is made by Mapp Biopharmaceutical Inc., a San Diego firm, was never tested on humans before the current Ebola outbreak.